The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus

A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes

(2011) Carl Asche et al.   CLINICAL THERAPEUTICS

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

(2011) G. E. Umpierrez et al.   DIABETES CARE

Antidiabetika

(2011) A. Wirth   INTERNIST

The Economics of Diabetes Prevention

(2011) William H. Herman   MEDICAL CLINICS OF NORTH AMERICA

Health Economics and Compliance of Vials/Syringes Versus Pen Devices: A Review of the Evidence

(2010) Carl V. Asche et al.   Diabetes Technology & Therapeutics

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis

(2009) Jaime A. Davidson et al.   CLINICAL THERAPEUTICS

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes

(2009) Bijan J. Borah et al.   CLINICAL THERAPEUTICS

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

(2009) Krzysztof Strojek et al.   CURRENT MEDICAL RESEARCH AND OPINION

Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes: Translating Research into Action for Diabetes (TRIAD)

(2009) L. N. McEwen et al.   DIABETES CARE

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

(2009) J. B. Buse et al.   DIABETES CARE

Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes: Which is better?

(2009) I. Lingvay et al.   DIABETES CARE

An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes

(2009) U. Dashora et al.   DIABETES OBESITY & METABOLISM

Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine

(2009) Julio Rosenstock et al.   Diabetes Technology & Therapeutics

Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial

(2009) Jorge L. Gross et al.   Diabetes Technology & Therapeutics

Effect of Two Starting Insulin Regimens in Patients with Type II Diabetes not Controlled on a Combination of Oral Antihyperglycemic Medications

(2009) Z. Milicevic et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE™ study

(2009) M. Yenigun et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix®30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

(2009) P. Valensi et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study

(2009) Gordon Goodall et al.   BMC Endocrine Disorders

Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs

(2008) G. Papa et al.   ACTA DIABETOLOGICA

Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure

(2008) Yumi Miyashita et al.   Cardiovascular Diabetology

Biphasic Insulin Aspart 30 Three Times Daily Is More Effective Than a Twice-Daily Regimen, Without Increasing Hypoglycemia, in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Drugs

(2008) W. Yang et al.   DIABETES CARE

Beneficial Effects of Insulin on Glycemic Control and  -Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy

(2008) H.-S. Chen et al.   DIABETES CARE

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

(2008) A. Liebl et al.   DIABETES OBESITY & METABOLISM

Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)

(2008) Motoyuki Tamaki et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients-The PREDICTIVE™ BMI clinical trial1

(2008) C. Fajardo Montañana et al.   DIABETIC MEDICINE

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study

(2008) H. C. Jang et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

(2008) Jianping Weng et al.   LANCET

Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up

(2007) M. Alvarsson et al.   DIABETES OBESITY & METABOLISM

Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11)

(2007) Koichi Hirao et al.   DIABETES RESEARCH AND CLINICAL PRACTICE